Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

Datopotamab Deruxtecan (Dato-DXd) in Combination With Pembrolizumab With or Without Platinum Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-Lung02)

NCT04526691

Conditions
Advanced or Metastatic NSCLC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Johns Hopkins Kimmel Cancer Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung Cancer

NCT03807778

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
View all 25 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

NCT06946797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0032 Anchorage, Alaska, United States
  • Local Institution - 0062 Los Angeles, California, United States
  • Local Institution - 0063 Boise, Idaho, United States
  • Local Institution - 0052 Boise, Idaho, United States
View all 38 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

NCT05172258

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope Antelope Valley Lancaster, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

NCT05353439

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +13 more
Locations
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chinese Participants With Relapsed/Refractory Small Cell Lung Cancer

NCT06799286

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations
  • Local Institution - 0004 Beijing, Beijing Municipality, China
  • Local Institution - 0003 Jinan, Shandong, China
  • Local Institution - 0001 Linyi, Shandong, China
  • Local Institution - 0005 Hangzhou, Zhejiang, China
View Trial Details

Related conditions